Stocktoria
Milestone Pharmaceuticals Inc. MIST
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2019-05-09
Milestone Pharmaceuticals Inc. financials (annual)
Bars are annual figures from 2018 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| R&D expense | $18.1M | $14.4M | $31.1M | $39.8M | $38.7M | $34.5M | $42.0M | $16.8M |
| Operating income | -$62.1M | -$42.1M | -$61.1M | -$59.6M | -$43.1M | -$50.7M | -$57.9M | -$23.8M |
| Interest expense | — | — | $2.6M | — | — | — | — | — |
| Income tax | — | — | — | — | — | -$17,000 | -$56,000 | $74,000 |
| Net income | -$63.1M | -$41.5M | -$59.7M | -$58.4M | -$42.9M | -$50.0M | -$55.2M | -$23.2M |
| EPS (diluted) | $-0.75 | $-0.67 | $-1.39 | $-1.38 | $-1.02 | $-1.70 | — | — |
| Operating cash flow | -$49.0M | -$28.8M | -$46.4M | -$52.5M | -$33.2M | -$50.7M | -$51.2M | -$21.0M |
| Free cash flow | -$49.3M | -$28.9M | -$46.5M | -$52.7M | — | — | -$51.6M | -$21.1M |
| Cash & equivalents | $73.0M | $25.3M | $13.8M | $7.6M | $114.1M | $72.3M | $119.8M | $85.9M |
| Inventory | $648,000 | — | — | — | — | — | — | — |
| Total assets | $113.6M | $75.5M | $75.2M | $74.5M | $119.8M | $150.0M | $123.4M | $88.1M |
| Total liabilities | $71.8M | $62.4M | $58.5M | $8.1M | $7.2M | $6.9M | $8.5M | $4.5M |
| Shareholders' equity | $41.8M | $13.1M | $16.8M | $66.3M | $112.6M | $143.1M | $114.9M | $83.5M |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.